Corcept Therapeutics, Inc. (CORT)
83.15
+0.17
(+0.20%)
USD |
NASDAQ |
Dec 09, 16:00
83.16
+0.02
(+0.02%)
After-Hours: 20:00
Corcept Therapeutics EPS Diluted (Quarterly): 0.1621 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| LeMaitre Vascular, Inc. | 0.7528 |
| United Therapeutics Corp. | 7.161 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.36M |
| Revenue (Quarterly) | 207.64M |
| Total Expenses (Quarterly) | 188.28M |
| Enterprise Value | 8.331B |
| Gross Profit Margin (Quarterly) | 97.79% |
| Profit Margin (Quarterly) | 9.32% |
| Earnings Yield | 1.05% |
| Operating Earnings Yield | 0.66% |
| Normalized Earnings Yield | 1.053 |